Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin αvβ3 to glycosaminoglycans

Journal of Biological Chemistry

Volumn 281, Issue 45, 2006, Pages 34179-34188

  Vallon, Mario ^a   Essler, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURVIVAL; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS;

BIOMARKERS; CELL CULTURE; CELLS; GROWTH KINETICS; MOLECULAR BIOLOGY; MUTAGENESIS;

TUMORS;

ARGINYLGLYCYLASPARTIC ACID; ENDOSIALIN; GELATINASE B; GLYCOSAMINOGLYCAN; GROWTH FACTOR; TUMOR ENDOTHELIAL MARKER 5; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL SURVIVAL; ENDOTHELIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; SOLUBILITY; UPREGULATION;

ANTIBODIES, MONOCLONAL; BETA-LACTAMASES; BINDING SITES; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOBLOTTING; INTEGRIN ALPHAVBETA3; LAMININ; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PLASMIDS; PROTEOGLYCANS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UMBILICAL VEINS;

EID: 33845962038     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M605291200     Document Type: Article

References (17)

1. Carmeliet, P., and Jain, R. K. (2000) Nature 407, 249-257
2. Bergers, G., and Benjamin, L. E. (2003) Nat. Rev. Cancer 3, 401-410
3. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., and Kinzler, K. W. (2000) Science 289, 1197-1202
4. Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., and St. Croix, B. (2001) Cancer Res. 61, 6649-6655
5. Lee, H. K., Seo, I. A., Park, H. K., and Park, H. T. (2006) FEBS Lett. 580, 2253-2257
6. Nanda, A., Carson-Walter, E. B., Seaman, S., Barber, T. D., Stampfl, J., Singh, S., Vogelstein, B., Kinzler, K. W., and St. Croix, B. (2004) Cancer Res. 64, 817-820
7. Bjarnadottir, T. K., Fredriksson, R., Hoglund, P. J., Gloriam, D. E., Lagerstrom, M. C., and Schioth, H. B. (2004) Genomics 84, 23-33
8. Fredriksson, R., Gloriam, D. E., Hoglund, P. J., Lagerstrom, M. C., and Schioth, H. B. (2003) Biochem. Biophys. Res. Commun. 301, 725-734
9. Ruoslahti, E., and Pierschbacher, M. D. (1987) Science 238, 491-497
10. Gray, J. X., Haino, M., Roth, M. J., Maguire, J. E., Jensen, P. N., Yarme, A., Stetler-Stevenson, M. A., Siebenlist, U., and Kelly, K. (1996) J. Immunol. 157, 5438-5447
11. Kaur, B., Brat, D. J., Devi, N. S., and Van Meir, E. G. (2005) Oncogene 24, 3632-3642
12. Yamamoto, Y., Irie, K., Asada, M., Mino, A., Mandai, K., and Takai, Y. (2004) Oncogene 23, 3889-3897
13. Varner, J. A., and Cheresh, D. A. (1996) Important Adv. Oncol. 69-87
14. Wang, T., Ward, Y., Tian, L., Lake, R., Guedez, L., Stetler-Stevenson, W. G., and Kelly, K. (2005) Blood 105, 2836-2844
15. Byzova, T. V., and Plow, E. F. (1998) J. Cell Biol. 143, 2081-2092
16. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996) Cell 85, 683-693
17. Essler, M., Amano, M., Kruse, H. J., Kaibuchi, K., Weber, P. C., and Aepfelbacher, M. (1998) J. Biol. Chem. 273, 21867-21874